Stem Cell Stocks 6/07/09: The Week That Was

Mark this week's post as the start of a possible stem cell stock turnaround. For the first time since January, every larger cap stem cell stock that we follow finished the week in positive territory. The sector has not done much in last three months with the exception of moves the last month by Geron and Cytori Therapeutics. There has been no notable catalyst that has caused this shift in activity. As a result, a follow up week will be big in determining if the stem cell stocks have new life.

Top Stem Cell Stock Performer(s) for Last Week:

- ThermoGenesis Corp (KOOL) = Up 38% for the week; Volume jumped significantly in KOOL during later part of the week. Either news is coming or institutions have begun to buy

Worst Stem Cell Stock Performer(s) for Last Week:

-Stem Cell Therapy Intl (SCII.OB) = Down -18; This stock has been in free fall from $0.12/share since April. Based on the chart, I wouldn't consider buying this until it hits $0.02 a share

Stem Cell Stocks Current Price and % Up or Down 6/1/09 - 6/5/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Cur Price: $1.66; Up 11%
Aastrom Biosciences (ASTM) = Cur Price: $0.361; Up 8%
BioTime, Inc. (BTIM) = Cur Price: $2.80; Up 10%
Celgene Corp (CELG) = Cur Price: $44.35; Up 5%
Cytori Therapeutics (CYTX) = Cur Price: $4.37; Up 15%
Geron Corp (GERN) = Cur Price: $6.83; Up 5%
ThermoGenesis (KOOL) = Cur Price: $0.73; Up 38%
Osiris Therapeutics (OSIR) = Cur Price: $14.11; Up 12%
StemCell Inc. (STEM) = Cur Price: $1.75; Up 7%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Cur Price: $0.155; Up 5%
Athersys Inc. (ATHX) = Cur Price: $0.899; Up 7%

Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.0725; Up 4%
Bioheart Inc. (BHRT) = Cur Price: $0.79; Down -6%
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.004; Down -2%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $1.25; Unchanged
Neuralstem (CUR) = Cur Price: $1.19; Up 13%
International Stem Cell (ISCO.OB) = Cur Price: $0.91; Down -9%
MultiCell Technologies (MCET.OB) = Cur Price: $0.0149; Down -10%
Pluristem Therapeutics (PSTI) = Cur Price: $1.27; Up 2%
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.049; Down -18%
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.048; Unchanged


Nothing has changed from the last few months.

- M&A (mergers and acquisitions) activity will be key. I can't believe that there hasn't been any activity yet, but I think it will happen as the economy improves

1 comment:

  1. They have stepped their every moves very carefully.On the other hand they are trying to consider their project delay for them.As they are going through a bad situation.

    Surge Protectors